Karolina Andersson Sundell

AstraZeneca (Sweden) — Sweden

Medicine · Health Sciences

28h-index2.2kcitations115works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(25), Medication Adherence and Compliance(24), Pharmaceutical Economics and Policy(21), Pharmaceutical studies and practices(20), Health Systems, Economic Evaluations, Quality of Life(19)

Publications115 total

Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink
Clinical Cardiology·2024· 4 citedOpen Access
Missed Opportunities in the Diagnosis of Heart Failure: A Real-World Assessment
ESC Heart Failure·2023· 8 citedOpen Access
Mind the gap: analysis of two pilot projects of a home telehealth service for persons with complex conditions in a Swedish hospital
BMC Health Services Research·2023· 6 citedOpen Access
Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry
Clinical Cardiology·2022· 10 citedOpen Access
Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction
Open Heart·2021· 6 citedOpen Access
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry
Journal of Cardiology·2021· 3 cited
Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study
European Heart Journal·2021
Health-related quality of life 1–3 years post-myocardial infarction: its impact on prognosis
Open Heart·2021· 61 citedOpen Access
Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling Claims
Therapeutic Innovation & Regulatory Science·2021· 4 cited
Assessment of The High risk and unmEt Need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource use, cost, and burden of illness in a commercially insured population
Journal of Diabetes and its Complications·2021· 3 citedOpen Access
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry
Endocrinology Diabetes & Metabolism·2020· 8 citedOpen Access
MULTI-MORBIDITY, FUNCTIONAL IMPAIRMENT AND MORTALITY IN OLDER PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION: A REPORT FROM THE TIGRIS REGISTRY
Journal of the American College of Cardiology·2020· 1 cited
Risk Analysis of Nonunion After First Metatarsophalangeal Joint Arthrodesis
Foot & Ankle Specialist·2020· 25 cited
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
International Journal of Cardiology·2020· 14 cited
Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register
BMJ Open Diabetes Research & Care·2020· 15 citedOpen Access
Upplevelser av att ha en känd barnmorska under graviditet,förlossning och eftervård hos den förlossningsrädda kvinnan och hennes partner : En kvalitativ intervjustudie
2020
Social kompetens inom vården : En studie ur ett medarbetarperspektiv.
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2020Open Access
Predicting risk of cardiovascular events 1 to 3 years post‐myocardial infarction using a global registry
Clinical Cardiology·2019· 28 citedOpen Access
P1932Predictors of DAPT use in patients beyond 1 year post myocardial infarction: Insights from the TIGRIS observational study
European Heart Journal·2019
2207Cardiovascular outcome in THEMIS -like type 2 diabetes patients in Sweden: a nationwide observational study
European Heart Journal·2019· 1 cited
page 1 of 6Next →

Frequent Co-authors

Max Petzold(14), Anders Carlsten(11), Anna K. Jönsson(8), Björn Eliasson(8), Mervete Miftaraj(8), Ann‐Marie Svensson(6), Soffia Guðbjörnsdóttir(6), Katja M. Hakkarainen(5), Staffan Hägg(5), Eva Lesén(5), Ann‐Charlotte Mårdby(5), Sofia Axia Karlsson(5), Hanna Gyllensten(4), Stuart Pocock(4), David Brieger(4), Mauricio G. Cohen(4), José Carlos Nicolau(4), Dirk Westermann(4), Satoshi Yasuda(4), Katarina Eeg‐Olofsson(4)